Magnetic susceptibility contrast variations in multiple sclerosis lesions
- 14 June 2015
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 43 (2) , 463-473
Abstract
Purpose: Recent magnetic resonance imaging (MRI) studies have revealed heterogeneous magnetic susceptibility contrasts in multiple sclerosis (MS) lesions. Due to its sensitivity to disease‐related iron and myelin changes, magnetic susceptibility‐based measures may better reflect some pathological features of MS lesions. Hence, we sought to characterize MS lesions using combined R2* mapping and quantitative susceptibility mapping (QSM).Materials and Methods: In all, 306 MS lesions were selected from 24 MS patients who underwent 7T MRI. Maps of R2*, frequency, and quantitative susceptibility were calculated using acquired multiecho gradient echo (GRE) phase data. Lesions were categorized based on their image intensity or their anatomical locations. R2* and susceptibility values were quantified in each lesion based on manually drawn lesion masks and compared between lesion groups showing different contrast patterns. Correlations between R2* and susceptibility were also tested in these lesion groups.Results: In 38% of selected lesions the frequency map did not show the same contrast pattern as the susceptibility map. While most lesions (93%) showed hypointensity on R2*, the susceptibility contrast in lesions varied, with 40% being isointense and 58% being hyperintense in the lesion core. Significant correlations (r = 0.31, P < 0.001) between R2* and susceptibility were found in susceptibility hyperintense lesions, but not in susceptibility isointense lesions. In addition, a higher proportion (74%) of periventricular lesions was found to be susceptibility hyperintense as compared to subcortical (53%) or juxtacortical (38%) lesions.Conclusion: Combining R2* and QSM is useful to characterize heterogeneity in MS lesions. J. Magn. Reson. Imaging 2016;43:463–473.Keywords
Funding Information
- National Center for Research Resources and the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health (P41 EB015909)
- Bayer Schering Pharma
- NIH (K23NS072366)
- Philips Healthcare
This publication has 40 references indexed in Scilit:
- Magnetic susceptibility anisotropy of human brain in vivo and its molecular underpinningsNeuroImage, 2012
- Morphology enabled dipole inversion for quantitative susceptibility mapping using structural consistency between the magnitude image and the susceptibility mapNeuroImage, 2012
- Whole brain susceptibility mapping using compressed sensingMagnetic Resonance in Medicine, 2011
- High-field (9.4T) MRI of brain dysmyelination by quantitative mapping of magnetic susceptibilityNeuroImage, 2011
- Quantitative susceptibility mapping of human brain reflects spatial variation in tissue compositionNeuroImage, 2011
- Susceptibility tensor imagingMagnetic Resonance in Medicine, 2010
- Layer-specific variation of iron content in cerebral cortex as a source of MRI contrastProceedings of the National Academy of Sciences, 2010
- Biophysical mechanisms of phase contrast in gradient echo MRIProceedings of the National Academy of Sciences, 2009
- Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imagingJournal of Magnetic Resonance Imaging, 2009
- High-field MRI of brain cortical substructure based on signal phaseProceedings of the National Academy of Sciences, 2007